Table 1.
Univariate analysis of LRDs associated with OS of patients with lung cancer underlying radiotherapy in TCGA.
| Characteristics | Univariate analysis | |
|---|---|---|
| HR (95% CI) | P value | |
| FADS2 | 0.662 (0.537 - 0.816) | < 0.001 |
| PARP1 | 0.555 (0.369 - 0.834) | 0.005 |
| STC2 | 0.774 (0.648 - 0.924) | 0.005 |
| DARS2 | 0.592 (0.407 - 0.860) | 0.006 |
| LMNB1 | 0.675 (0.507 - 0.897) | 0.007 |
| ATP2A2 | 0.609 (0.424 - 0.873) | 0.007 |
| RCC2 | 0.598 (0.406 - 0.880) | 0.009 |
| PHGDH | 0.821 (0.708 - 0.952) | 0.009 |
| UPB1 | 1.246 (1.055 - 1.473) | 0.010 |
| ASPM | 0.773 (0.634 - 0.943) | 0.011 |
| PSTPIP1 | 1.382 (1.066 - 1.792) | 0.015 |
| KIF21A | 0.703 (0.528 - 0.935) | 0.016 |
| CAPN3 | 1.267 (1.040 - 1.543) | 0.019 |
| ALDH18A1 | 0.664 (0.472 - 0.934) | 0.019 |
| HNRNPU | 0.496 (0.275 - 0.895) | 0.020 |
| MKI67 | 0.787 (0.637 - 0.972) | 0.026 |
| VDAC1 | 0.625 (0.405 - 0.966) | 0.034 |
| RTBDN | 0.896 (0.809 - 0.993) | 0.036 |
| ADAMTS3 | 0.848 (0.726 - 0.991) | 0.038 |
| PITX3 | 0.881 (0.780 - 0.995) | 0.041 |
| ASIC2 | 0.852 (0.728 - 0.997) | 0.046 |
| ZMPSTE24 | 0.619 (0.385 - 0.993) | 0.047 |
| HSPA4 | 0.637 (0.406 - 0.998) | 0.049 |